Government bought cheaper blood products with higher risk, document suggests
by Pol Allingham
Apr 14, 2024
3 minutes
A newly disclosed document suggests the government “was willing to endanger lives” by buying cheaper blood products more likely to be infected with hepatitis, campaigners have said.
Minutes from a telephone conversation in 1976 suggest the Department of Health was offered two forms of blood products – one with a lower hepatitis risk and a cheaper option “proven” to carry a “significantly higher risk”.
Kryobulin 1 came from volunteers but the “significantly cheaper” option, Kryobulin 2, came
You’re reading a preview, subscribe to read more.
Start your free 30 days